Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey November 23, 2015
Comparative phenomenology of psilocybin experiences in research and non-research settings November 1, 2015
Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts November 1, 2015
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin October 6, 2015
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity August 22, 2015
